New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women
Open Access
- 28 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medical Genetics
- Vol. 12 (1), 60
- https://doi.org/10.1186/1471-2350-12-60
Abstract
Vaspin and omentin are recently described molecules that belong to the adipokine family and seem to be related to metabolic risk factors. The objectives of this study were twofold: to evaluate vaspin and omentin circulating levels and mRNA expression in subcutaneous and visceral adipose tissues in non-diabetic morbidly obese women; and to assess the relationship of vaspin and omentin with anthropometric and metabolic parameters, and other adipo/cytokines.Keywords
This publication has 28 references indexed in Scilit:
- Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnanciesMetabolism, 2011
- Adipokines as novel modulators of lipid metabolismTrends in Biochemical Sciences, 2009
- Serum Vaspin Concentrations in Human Obesity and Type 2 DiabetesDiabetes, 2008
- Lipocalin-2 Is an Inflammatory Marker Closely Associated with Obesity, Insulin Resistance, and Hyperglycemia in HumansClinical Chemistry, 2007
- Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin actionAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Signalling role of adipose tissue: adipokines and inflammation in obesityBiochemical Society Transactions, 2005
- Adiponectin – a key adipokine in the metabolic syndromeDiabetes, Obesity and Metabolism, 2005
- A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric bandingInternational Journal of Obesity, 2002
- Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by GlucocorticoidJournal of Clinical Endocrinology & Metabolism, 1998